NCT01135550 Low Dose Versus Usual Dose Dexamethasone for Symptom Control in Children Undergoing Cranial or Craniospinal Radiation Status TERMINATED Phase PHASE3
NCT01114997 Effect of Lidocaine and Esmolol to Improve the Quality of Recovery Status TERMINATED Phase PHASE4
NCT01095536 Risk Factors for Shoulder Pain and Emesis After Laparoscopic Cholecystectomy Status UNKNOWN Phase N/A
NCT01088022 Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting Status UNKNOWN Phase PHASE3
NCT01074697 Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin Status COMPLETED Phase PHASE3
NCT01055236 Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients Status COMPLETED Phase PHASE4
NCT01052844 Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy Status COMPLETED Phase PHASE3
NCT01047371 Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty Surgery Status COMPLETED Phase N/A
NCT01041183 The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy Status UNKNOWN Phase NA
NCT01013012 Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery Status COMPLETED Phase PHASE4
NCT01007500 Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery Status COMPLETED Phase PHASE4
NCT00982995 Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients Status TERMINATED Phase PHASE2
NCT00970905 Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy Status COMPLETED Phase PHASE2
NCT00956215 Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients Status COMPLETED Phase NA
NCT00954291 An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects Status UNKNOWN Phase N/A
NCT00947128 To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions Status COMPLETED Phase PHASE1
NCT00946387 To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00940368 A Study to Assess the Anti-Emetic Efficacy of Ginger in Children and Adolescents Receiving Chemotherapy Status UNKNOWN Phase PHASE3